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Results and discussion. The data showing the effect of EMS 
on different types of spermatogonia are given in the table. 
At the dose of 100 mg/kg, only a small fraction of all 
A types, In and B spermatogonia were reduced by 3 days 
after EMS administration. At high er doses (300 and 400 
mglkg) all types of spermatogonia were affected within 24 h 
with maxim um killing of A 1- A4 cells. Highly profound deple-
tion (96%) in Pl cells, 3 days after administration of 300 and 
400 mg/kg, reflected killing of a large fraction of A4 and In 
spermatogonia. Similarly 97% decrease in the nurnber of 
B cells, 3 days after treatment with the same doses indicates 
darnage of late A3 and early A4 cells, since Sperrnatogenesis 
is a dynamic process, the cell-types scored are different 
from the cell types treated. Although EMS was found to 
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affect most of the types of differentiating spermatogonea, 
all the cells are not uniformly killed. 
EMS increases the incidence of dominant Jethals in the post 
meiotic . phase of spennatoyenesis largely affecting the 
spermatids and the sperms8- 1 . EMS has also recently been 
reported to induce in vivo somatic mutation in mice at 
relatively lower dosage levels of 50 and 100 mg/kg 12• 
However, 300 mg/kg of EMS has failed to increase the 
mutation frequency in the specific locus test in the mouse 
spermatogonia 13. The present study shows that EMS is 
capable of inflicting biological darnage in the premeiotic 
phase and affects the various spermatogomal cells in a 
differential manner. 
7 D .. Bhattacharjee, T. K. Shetty and K. Sundaram, 3rd Ann. 
Meet. environm. Mutagen Soc. India 1978, abstr. 
8 B.M. Cattanach, C.E. Pollard and J.H. lsaacson, Mutat. Res. 
6, 297 ( 1968). 
9 U.H. Ehling, R.B. Cumming and M. V. Mailing, Mutat. Res. 
5, 417 (1968). 
lO W.M. Generosa and W.L. Russen, Mutat. Res. 8, 589 (1969). 
11 M. Partington and H. Jackson, Genet. Res. 4, 333 (1963). 
12 L. B. Russen, Archs Toric. 38, 75 (1977). 
13 U.H. Ehling and W.L. Russell, Genetics 61, 14 (1969). 
Comparative studies on the covalent binding of the carcinogen benzo(a)pyrene to DNA in various model systems1 
W. Jaggi, W.K. Lutz and Ch. Schlatter2 
Institute of Toxico/ogy, Federal Institute of Technology and University of Zurich, CH-8603 Schwerzenbach (Switzerland), 
10 January 1979 · 
Summary. The covalent binding of tritiated benzo(a)pyrene (BP) to DNA has been determined in rat liver in vivo, in rat 
liver perfused in situ, after incubation of BP with liver single cells, with liver homogenate, with liver microsomes and 
DNA, with fibroblasts from a rat granulorna pouch, and with · 2 cell lines. Li ver single cells were found to be a valuable 
compromise between the rnost sensitive system (microsomal incubation of BP with DNA) and the biologically most 
relevant system (in vivo ). 
lt is now widely accepted that the first step in the chemical 
. induction of a tumour involves binding of the chemical or 
one of its metabolites to a biological macromolecule3• 
Good correlations between that binding and carcinogenici-
ty have been found particularly with DNA as target male· 
cules4• Before such a binding can occur most substances 
have first to be converted by enzymatic action to reactive 
metabolites5• Only a very small fraction reacts with nucleic 
acids so that this type of binding can normally be measured 
only by using radiolabelled chemicals. Because of the cost 
of radioactive compounds and the limited availability of 
high specific activities, the yield of chemical bound to DNA 
as a fraction of the total amount of chemical used should be 
optimized so that a radioactivity on DNA can be measured 
from a minimal dose administered. 
We have measured the binding of a standard carcinogen 
(tritiated benzo(a)pyrene, BP) to DNA in various rnodel 
systems and have calculated the specific binding of BP per 
mg DNA as well as the radioactivity which can be 
recovered in a scintillation vial from the total DNA isolat-
ed. This comparison will help to choose the most appro-
priate model system f<;>r measuring the binding of other 
suspected carcinogens to DN A. 
Materials and methods. Chemicals. Inactive BP was ob-
tained from Fluka AG, Buchs, Switzerland. Generally 
tritiated BP (purified on silica-gel before use) was from the 
Radiochemical Centre, Arnersharn, England, 36 Ci/mmole. 
NADP, glucose-6-phospha:te and glucose-6-phosphate-
dehydrogenase were from Boehringer, Mannheim, GFR. 
The other reagents used were of the purest grade available 
from Merck, Darmstadt, GFR . 
Isolation of DNA. DNA was isolated according to Markov 
and Ivanov6 with the modifications described before7• 
Rat liver, in vivo. 0.5 ml of a BP solution in oil was given to 
male rats (SIV 50, Sprague-Dawley derived, about 300 g) 
by i.p. injection (4 mg, 109 dpm). After 50 h, the liver was 
excised and DNA was isolated. 
Liver perfusioii in situ. Fernale rats (250 g) were given 
60 mg/kg pentobarbitone and the liver was perfused in situ 
for 2 h by cannulation of the portal vein (in) and the 
thoracic portion ofthe vena cava (out). Tritiated BP (0.6 Jlg, 
1.83 ·108 dpm) was deposited on the bottom of a 25 ml 
conical flask by evaporating the hexane from the stock 
solutionunder a stream of nitrogen and 20 ml of perfusion 
buffer (0.8% NaCl, 0.04% KCI, 0.005% Na2HP04, 0.006% 
KH2P04, pH 7.6 with NaOH) was added. Oxygen .was 
supplied by keeping the perfusion buffer reservoir at 37 oc 
under oxygen. The blood present in the liverat the begin-
ning of the perfusion was included in the closed circuit in 
order to solubilize the BP. 
. Li ver single cells. Single cells were prepared after perfusion 
of a rat liver with a solution of collagenase8• BP (0.73 Jlg, 
2.05 · 108 dpm) was added to a 25 ml conical flask as 
described above and the cells were incubated for 3 h at 
37 oc in Hanks' solution. 
Liver homogenate. Rat liver was treated in a loose-fitting 
Potter-Elvehjem homogenizer with a teflon pestle in 3 vol. 
of buffer (0.25 M sucrose, 0.01 M Tris/HCI, pH 7.4). The 
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homogenate (about 30 ml) was ip.cubated under oxygen in 
a 300 ml conical flask, prepared with BP (11 ~g, 3.7 · 108 
dpm) as above, in a shaking water-bath at 37 "C, and 
aliquots were taken for the isolation of DNA. 
Liver microsomes incubated with DNA. Microsomes were 
prepared according to Schenkman and Cinti9 with modifi-
cations described elsewhere 10• The incubation mixttue con-
sisted of 50 mM Tris/HCl, pH 7.5, 2.5 mM KCl, 5 mM 
MgC12, 2.5 mM glucose-6-phosphate, 1 mM NADP, 
1 U/ml glucose-6-phosphate-dehydrogenase, 0.7-2.2 ~g BP, 
0.64-3.66 mg DNA and had a total volume of 4 ml. The 
incubation was performed in a 25 m1 conical flask at 37 oc 
in a shaking water-bath for 90 min. 
A control incubation of BP with DNA and the cofactor 
system but without microsomes gave rise to $e appreciable 
binding of 190 dpm/mg per 107 dpm (3 experiments). This 
radioactivity was not extractab1e from DNA with ethanol 
and ether. This nonenzymatic binding is in agreement with 
earlier reports11, where a covalent binding depending on 
time, light and temperature was also found. 
Fibroblasts from rat granuloma pouch. Fibrob1asts were 
prepared in Petri dishes (8 cm diameter) according to 
Maier et al. 12• BP (8 ~g, 2.1· 109 dpm) in acetone (fmal 
concentration 0.07%) was added to the culture medium 
when the cells bad reached confluency. After 12 or 24 h, 
this medium was substituted by the lysing medium used for 
the first step of the DNA isolation procedure6 and the cells 
were collected from the dishes with a scalpel. 
Cell lines. Rahbit cornea (SIRC) and monkey kidney 
(VERO) cells were grown to confluency in 7x 10 cm 
culture bottles. The medium was decanted into a conical 
flask, the bottom of which was covered with radioactive BP 
(0.08-0.4 11g, 0.215-1.08 ·108 dpm). After dissolving the BP 
by shaking for 10 min at 37 "C, the medium was poured· 
back into the culture bottles and the cells were incubated 
for 4 h. The medium was removed, lysing medium (Markov 
and Ivanov6) was added and the cells were scratched loose 
with a ruhher scraper. 
Results and discussion. Averaged results obtained from the 
different systems are compiled in the table. Column 1 with 
the specific binding shows that the amount of benzo(a}py-
rene bound per mg DNA varies by more than 3 orders of 
magnitude between the 2 extreme systems, in vivo and 
Binding of · tritiated benzo(a)pyrene to DNA in various model 
systems 
System 
Rat liver, in vivo 
Liver perfusion 

























1400± 600 (3) 
850± 600 (3) 
Total dpm available 
yield on total DNA 












The SD and the nurober of determinations is given if applicable. 
* With optimal conditions (0.74 ~g BP, 0.64 mg DNS, 0.53 mg 
microsomal protein); see 'Materials and methods'. 
incubation ofBP with DNA in the presence ofmicrosomes. 
Liver perfusion and liver homogenate yield a specific 
binding which is only slightly larger than the one found 
with the intact animal. There is therefore no real advantage 
in choosing one of these systems since the lower sensitivity 
of the in vivo experiment is more than compensated by the 
advantage of having an intact organism as well as by the 
fact that other organs beside the liver can simultaneously 
be analyzed. 
The cellular systems investigated differ substantially from 
each other and the cell lines revealed a large variability 
between single experiments, which is probably due to 
changes in the activating enzyme systems. The experiments 
with the liver single cells showed a rernarkably small 
variability and a high specific binding. This system there-
fore represents a valuable compromise between the in vivo 
experiment and the microsomal incubation with respect to 
sensitivity, reproducibility and biological relevance. 
The · specific binding discussed so far gives' a measure of 
how many molecules BP are bound per mg DNA; it can be 
used for choosing the most appropriate system for studies 
on the chemical nature of the BP-nucleotide adduct where 
it is important to have a maximal fraction of modified 
nucleotides. 
If, however, the question is whether a chemical binds to 
DNA at all, the amount of DNA which can be obtained 
from the different systerns is also important, since the more 
DNA can be brought into a scintillation vial, the better is 
the limit of detection for a bound radioactive molecule. 
This yield of DNA is given in column 2 of the table and is 
shown to vary by a factor of 100. A multiplication of the 
values of column 1 and 2 results in the radioactivity 
exfected on the total DNA from an experiment with 
10 dpm starting activity (column 3). Thanks to the high 
yield of DNA from the experiments with low specific 
binding (in vivo, perfusion, homogenate ), the various 
model systems differ only by a factor of about 30 with 
respect to the Iimit of detection, ap.d the liver single cells 
are only 5 times less sensitive than the microsomal incuba-
tion. 
Based upon the values in column 3 and the biological 
relevance of the different systems, preference will be given' 
generally to the in vivo experiment. However, if the 
amount of radioactivity available is a very limiting factor, 
liver single cells can be recommended or, for structural 
analysis of DNA-bound compounds, an · incubation of 
DNA in the presence of microsomes. 
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